UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000021954 |
|---|---|
| Receipt number | R000025314 |
| Scientific Title | Examination of the efficacy of dapagliflozin in patients with type 2 diabetes |
| Date of disclosure of the study information | 2016/05/01 |
| Last modified on | 2022/10/28 11:09:08 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2016/04/17 19:59:21 | ||
| 2 | Update | 2016/10/28 10:42:37 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 3 | Update | 2016/10/28 10:45:03 | Interventions/Control_1 Interventions/Control_1 |
|
| 4 | Update | 2016/10/28 10:46:17 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 5 | Update | 2016/10/28 10:49:01 | Recruitment status |
|
| 6 | Update | 2019/04/24 07:03:54 | Key inclusion criteria Key inclusion criteria |
|
| 7 | Update | 2019/10/25 15:23:05 | Interventions/Control_1 Interventions/Control_1 |
|
| 8 | Update | 2020/04/24 12:04:43 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 9 | Update | 2020/04/24 12:12:33 | Interventions/Control_1 Interventions/Control_1 |
|
| 10 | Update | 2020/04/24 12:13:43 | Interventions/Control_1 |
|
| 11 | Update | 2020/04/24 12:18:34 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 12 | Update | 2020/10/23 11:51:11 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Organization Organization Address Address Tel |
|
| 13 | Update | 2022/10/28 11:09:08 | Date of IRB Last follow-up date |
